Elevar Therapeutics’ Post

The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies. Effects of MAGL and FAAH on tumour-immune interactions. https://lnkd.in/gNei9eiU

BIO-ACADEMIA: In a stride towards enhancing HER2-positive breast cancer treatment, Korean scientists at Korea University have introduced HVH-2930, an HSP90 inhibitor poised to redefine therapeutic outcomes. Click to read: https://lnkd.in/gAx3Sebz #academia #therapeutic #breastcancer #cancertreatment #inhibitor #biovoicenews

Duke-NUS researchers have made a significant breakthrough in understanding why certain pancreatic and colorectal cancers do not respond to Wnt inhibitors, a promising type of cancer medication currently in development. Their findings, published in Science Advances, not only reveal a potential new target for cancer treatment, but also introduce a potential screening method for identifying patients who will not benefit from this medication once it is made available. Read more about it from the link in the comments. 📸: istock #DukeNUSResearch #DukeNUS #pancreaticcancer #colorectalcancer #cancertherapy #medication

🌿 Exciting breakthrough in cancer research! This study unveils the potent cytotoxic activity of A. catechu seed extract against oral squamous carcinoma cells. 💊 These findings suggest a promising avenue for developing novel therapeutic strategies against this challenging disease. #CancerResearch #Apoptosis #TherapeuticInnovation 📊🔬

🎯 Discover Syndecan-1 (#SDC1): a key transmembrane proteoglycan and a potential breakthrough target in pancreatic cancer therapy. Dive deeper into its role and impact. 📄 Read more: bit.ly/3QWPqun #SDC1 #CancerResearch #PancreaticCancer

Unlocking New Insights in Pancreatic Cancer Treatment! 🚀 We're excited to share key takeaways from our latest research article, "Nanoformulation of Dasatinib Cannot Overcome Therapy Resistance of Pancreatic Cancer Cells with Low LYN Kinase Expression." This groundbreaking study explores the challenges and innovative solutions in treating pancreatic ductal adenocarcinoma (PDAC). Article Link: https://lnkd.in/g2DbED5z #CancerResearch #PancreaticCancer #Nanomedicine #Dasatinib #Biomarkers

Establishment, characterization, and biobanking of 36 pancreatic cancer organoids: prediction of metastasis in resectable pancreatic cancer https://lnkd.in/gpeZmaBs

Resurgence of Smart 🎯 Chemo is on the rise 🚀 , led by Antibody Drug Conjugates that precisely deliver cytotoxic drugs 💊  to tumor cells whilst sparing normal cells the toxicity ☢ of chemotherapeutic agents. Here is a good introduction to ADCs.  https://lnkd.in/e69-_g_g #chemotherapy #adc #cancer #cancerresearch #cancertreatment #oncology #oncologyresearch #precisiononcology #precisionmedicine 

Attend our webinar with MAIA at 4 PM tomorrow, to discover why the U.S. FDA granted orphan drug status to MAIA’s leading asset THIO for glioblastoma treatment, following previous designations for Liver and Small Cell Lung Cancer. https://hubs.la/Q02c1dMm0

Watch our webcast with expert faculty to gain practical insights into the importance of biomarker testing in patients diagnosed with metastatic colorectal cancer (#mCRC), optimizing biomarker testing, and role of biomarkers in guiding treatment selection. https://lnkd.in/em83Cvat